{"title":"阿戈美拉汀是另一种瑞波西汀吗?这又是一个发表偏见的例子。","authors":"Sumeet Gupta","doi":"10.1192/pb.38.2.88","DOIUrl":null,"url":null,"abstract":"I read the special article about agomelatine with interest.1 The authors state that controlled studies have suggested a favourable efficacy and tolerability profile of agomelatine in depression. This statement is not entirely accurate.","PeriodicalId":90710,"journal":{"name":"Psychiatric bulletin (2014)","volume":"38 2","pages":"88"},"PeriodicalIF":0.0000,"publicationDate":"2014-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1192/pb.38.2.88","citationCount":"1","resultStr":"{\"title\":\"Agomelatine - is it another reboxetine? Another case of publication bias.\",\"authors\":\"Sumeet Gupta\",\"doi\":\"10.1192/pb.38.2.88\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"I read the special article about agomelatine with interest.1 The authors state that controlled studies have suggested a favourable efficacy and tolerability profile of agomelatine in depression. This statement is not entirely accurate.\",\"PeriodicalId\":90710,\"journal\":{\"name\":\"Psychiatric bulletin (2014)\",\"volume\":\"38 2\",\"pages\":\"88\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1192/pb.38.2.88\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychiatric bulletin (2014)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1192/pb.38.2.88\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatric bulletin (2014)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1192/pb.38.2.88","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Agomelatine - is it another reboxetine? Another case of publication bias.
I read the special article about agomelatine with interest.1 The authors state that controlled studies have suggested a favourable efficacy and tolerability profile of agomelatine in depression. This statement is not entirely accurate.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
